ConductCognition
  • Domains

    Tests

    • Processing speed43
    • Attention113
    • Working memory50
    • Executive function143
    • Episodic memory72
    • Response inhibition9
    • Social cognition75
    • Language42

    Most used

    Evidence

    1. Verbal Fluency TestGradeA
    2. Stroop Color-Word TestGradeA
    3. Trail Making TestGradeA
    4. N-Back TaskGradeA
    5. Go/No-Go TaskGradeA
    6. Digit Span TestGradeA
    7. Symbol Coding TestGradeA
    8. Verbal Learning TestGradeA
    REDTry it nowStroop Color-Word Test
    All 547 tests

    Browse by

    • Phone290
    • Tablet323
    • Untimed326
    • Up to 5 minutes69
    • Evidence grade A40
  • First studies

    Grade, length

    • Reaction Time StudyGradeA7 min
    • Pilot ScreeningGradeA15 min
    • Medication StudiesGradeA−26 min
    • Language-Minimized ScreeningGradeA−30 min

    Age groups

    • Older Adult Executive SpeedGradeA20 min
    • School-AgeGradeA−33 min

    Memory

    • At-Home MemoryGradeA26 min
    • Working Memory and LearningGradeA−19 min
    • Associative MemoryGradeB32 min
    • Working Memory CapacityGradeB34 min

    Language and perception

    • LanguageGradeA−33 min
    • Visual PerceptionGradeB27 min
    • Listening and Auditory ProcessingGradeB31 min

    Executive function and attention

    • Executive ControlGradeA18 min
    • Attention and ImpulsivityGradeA−26 min
    • Visual AttentionGradeB27 min
    • Creativity and Flexible ThinkingGradeB30 min
    • Reasoning and SpatialGradeB32 min

    Movement

    • Motor and AttentionGradeA−29 min
    • Motor LearningGradeB34 min

    Behavior, mood and choice

    • Food Choice and Self-ControlGradeA−29 min
    • Sleep and FatigueGradeB23 min
    • Social CognitionGradeB23 min
    • Impulsivity and Substance UseGradeB26 min
    • Emotion and MoodGradeB28 min
    • Decisions and RewardGradeB29 min
    All 26 batteries

    Find one

    Up to 15 minutes2Up to 30 minutes19Phone8
    Test order labBattery gradesHow batteries work
  • Use and evidence

    • Overview
    • Compare all 547 tests
    • Test-retest
    • Reliability and validity
    • Battery grades26
    • Download and cite

    Clinical trials

    • Overview
    • By condition25
    • By test101
    • Trial design benchmark
    • Cognitive outcomes, 2026

    Conditions

    Registered studies

    • Dementia and Alzheimer's1,673
    • Aging, frailty and exercise1,398
    • Depression and bipolar disorder1,247
    • Stroke1,233
    • Substance use and addiction895
    • Parkinson's disease892
    • Cancer760
    All 25 conditions
    16,361Registered studies name a cognitive test in an outcome measure11,688 name a test you can run hereExplore the studies
  • 1

    Build

    • Study design
    • Customize tests
    • Repeat visits
    • Study cost calculator
    2

    Recruit

    • Recruitment setup
    • Prolific
    • Sona Systems
    • CloudResearch Connect
    • Qualtrics
    3

    Run

    • Remote testing
    • Participant devices
    • Phone timing check
    • Offline edition
    4

    Results

    • Automated scoring
    • Test norms
    • Study Quality Monitor
    • Data export
    Platform overview

    Compliance

    • HIPAA-ready testing
    • US clinical research
    • Data Policy
    • Privacy Policy
    • Terms of Use
  • Research areas

    Tests used in each

    • Aging and dementia188
    • Decisions and reward105
    • Child development and education87
    • Language and bilingualism64
    • Social behavior62
    • Psychiatric groups35
    • Training and intervention28
    • Mood, anxiety and trauma25
    • Substance use and impulsivity25
    • Neurological and movement research19
    • Brain injury and concussion14
    • Sleep and fatigue14
    • ADHD11
    • Eating and obesity8
    • Medication and drug trials8

    Research settings

    • Student participant pools
    • Teaching a class
    • Clinical trials
    • US clinical research
    • Sites without internet
    Planning a study?
  • Methods

    • How evidence grades work
    • How test batteries work
    • How test order works
    Methods and questions

    Help

    • FAQ
    • Recruitment guides
    • Compare platforms

    Updates

    • Blog
    • New tests by email
    Latest post10 November 2026What you can do in ConductCognition todayA short tour of ConductCognition as it stands on 10 November. After this, we'll post when something changes how you run a study.Read the post
  • Pricing
Start Free
Log In
Log InStart Free
  1. Home
  2. /Data
  3. /Clinical trials
  4. /Tests
  5. /Paced Visual Serial Addition Test

Clinical trials data

Paced Visual Serial Addition Test in clinical trials: 337 registered studies

Every registered study on ClinicalTrials.gov that names the Paced Visual Serial Addition Test in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.

Registered studies name it in an outcome measure
337
Name it in a primary outcome, 42%
140 of 337
Against similar tests
Of studies started 2021 to 2025 name it, against 2.4% in 2016 to 2020
1.3%
By year
Median participants per study
61
By phase
Try the Paced Visual Serial Addition Test

The conditions it is used in

Each study counted once in each condition group it falls in.
  1. Multiple sclerosis169 studies, 61 as a primary outcome

  2. Substance use and addiction30 studies, 13 as a primary outcome

  3. Pain and fatigue28 studies, 13 as a primary outcome

  4. Sleep and sleep disorders20 studies, 15 as a primary outcome

  5. Brain injury and concussion18 studies, 13 as a primary outcome

  6. Depression and bipolar disorder17 studies, 7 as a primary outcome

  7. Cancer15 studies, 8 as a primary outcome

  8. Schizophrenia and psychosis13 studies, 3 as a primary outcome

  9. Anxiety, PTSD and OCD13 studies, 8 as a primary outcome

  10. Healthy volunteers10 studies, 5 as a primary outcome

  11. Aging, frailty and exercise9 studies, 6 as a primary outcome

  12. Obesity and diabetes7 studies, 1 as a primary outcome

  13. Stroke6 studies, 3 as a primary outcome

  14. Parkinson's disease6 studies, 2 as a primary outcome

  15. Dementia and Alzheimer's5 studies, 3 as a primary outcome

  16. Mild cognitive impairment4 studies, 3 as a primary outcome

  17. Cognitive impairment and decline3 studies, 1 as a primary outcome

  18. Delirium, surgery and intensive care3 studies, 0 as a primary outcome

  19. Cardiovascular disease3 studies, 2 as a primary outcome

  20. Lung disease3 studies, 2 as a primary outcome

  21. ADHD2 studies, 2 as a primary outcome

  22. Epilepsy2 studies, 1 as a primary outcome

  23. Autism1 study, 0 as a primary outcome

  24. COVID-19 and long COVID1 study, 1 as a primary outcome

  25. Other conditions27 studies, 12 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

The Paced Visual Serial Addition Test is a primary outcome in 42% of its studies. Across the 11 processing speed tests with a page here, the median is 42%.
  1. Motor Sequence Task53% of 30 studies

  2. Serial Reaction Time48% of 27 studies

  3. Arithmetic Fluency Task47% of 101 studies

  4. Mirror Tracing Task43% of 23 studies

  5. Symbol Scan Task42% of 129 studies

  6. Paced Visual Serial Addition Test42% of 337 studies

  7. Simple Reaction Time40% of 210 studies

  8. Finger Tapping Task38% of 144 studies

  9. Pattern and Letter Comparison35% of 147 studies

  10. Symbol Coding31% of 1,457 studies

  11. Trail Making Test31% of 2,293 studies

Studies by start year

1.3% of the registered studies that started in 2021 to 2025 name it, against 2.4% of those that started in 2016 to 2020. 2026 is partly planned starts.
02000: 0 studies, 0 with a test as a primary outcome20002001: 1 studies, 0 with a test as a primary outcome2002: 5 studies, 1 with a test as a primary outcome2003: 3 studies, 2 with a test as a primary outcome2004: 2 studies, 1 with a test as a primary outcome2005: 0 studies, 0 with a test as a primary outcome20052006: 4 studies, 0 with a test as a primary outcome2007: 4 studies, 0 with a test as a primary outcome2008: 5 studies, 1 with a test as a primary outcome2009: 12 studies, 6 with a test as a primary outcome2010: 9 studies, 5 with a test as a primary outcome20102011: 12 studies, 6 with a test as a primary outcome2012: 10 studies, 4 with a test as a primary outcome2013: 16 studies, 9 with a test as a primary outcome2014: 18 studies, 10 with a test as a primary outcome2015: 18 studies, 7 with a test as a primary outcome20152016: 25 studies, 9 with a test as a primary outcome2017: 20 studies, 7 with a test as a primary outcome2018: 22 studies, 9 with a test as a primary outcome2019: 29 studies, 11 with a test as a primary outcome2020: 13 studies, 6 with a test as a primary outcome20202021: 21 studies, 11 with a test as a primary outcome2022: 20 studies, 7 with a test as a primary outcome2023: 21 studies, 9 with a test as a primary outcome2024: 19 studies, 9 with a test as a primary outcome2025: 8 studies, 5 with a test as a primary outcome20252026: 16 studies, 4 with a test as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table
Registered studies by start year
Start yearStudiesA test as a primary outcome
200000
200110
200251
200332
200421
200500
200640
200740
200851
2009126
201095
2011126
2012104
2013169
20141810
2015187
2016259
2017207
2018229
20192911
2020136
20212111
2022207
2023219
2024199
202585
2026164

Phases and study sizes

By phase

  • Early phase 15 studies, 2 as a primary outcome
  • Phase 121 studies, 8 as a primary outcome
  • Phase 1/218 studies, 5 as a primary outcome
  • Phase 230 studies, 9 as a primary outcome
  • Phase 2/38 studies, 4 as a primary outcome
  • Phase 320 studies, 2 as a primary outcome
  • Phase 419 studies, 10 as a primary outcome
  • Not applicable168 studies, 73 as a primary outcome
  • Observational48 studies, 27 as a primary outcome

Participants per study

1020501002005001,000
  • Phase 129 median, 18 to 70
  • Phase 1/241 median, 30 to 69
  • Phase 264 median, 37 to 115
  • Phase 3792 median, 300 to 998
  • Phase 480 median, 29 to 139
  • Not applicable50 median, 30 to 96
  • Observational93 median, 60 to 150
Participants per study. The bar spans the middle half of the studies in each phase, the mark is the median, and the axis is logarithmic. Phases with fewer than 10 studies that give a size are left out.
Show as a table
Participants per study that names the Paced Visual Serial Addition Test, by phase
PhaseStudies with a sizeMedianMiddle half
Phase 1212918 to 70
Phase 1/2174130 to 69
Phase 2306437 to 115
Phase 320792300 to 998
Phase 4198029 to 139
Not applicable1665030 to 96
Observational489360 to 150

When trials measure it

Half of the primary outcomes that name the Paced Visual Serial Addition Test are measured within 12 weeks of the start, and the middle half from 1 week to 8 months. 126 primary outcomes give a duration.

Latest time point of each outcome

  • Within a day54 outcomes, 25 as a primary outcome
  • Up to 4 weeks40 outcomes, 16 as a primary outcome
  • 1 to 3 months72 outcomes, 31 as a primary outcome
  • 3 to 6 months50 outcomes, 20 as a primary outcome
  • 6 to 12 months41 outcomes, 17 as a primary outcome
  • 1 to 2 years27 outcomes, 9 as a primary outcome
  • Over 2 years24 outcomes, 8 as a primary outcome
  • No duration given29 outcomes, 14 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

308 of the 337 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

  • Recruiting36 studies, 17 as a primary outcome
  • Not yet recruiting17 studies, 5 as a primary outcome
  • Active, not recruiting6 studies, 4 as a primary outcome
  • Completed202 studies, 86 as a primary outcome
  • Stopped early30 studies, 8 as a primary outcome
  • Status unknown46 studies, 20 as a primary outcome

What they test

  • Behavioral88 studies, 33 as a primary outcome
  • Drug104 studies, 37 as a primary outcome
  • Device42 studies, 23 as a primary outcome
  • Dietary supplement8 studies, 1 as a primary outcome
  • Procedure14 studies, 5 as a primary outcome
  • Diagnostic test7 studies, 3 as a primary outcome
  • Biological18 studies, 3 as a primary outcome
  • Radiation3 studies, 3 as a primary outcome
  • Combination product2 studies, 0 as a primary outcome
  • Other93 studies, 39 as a primary outcome
  • None given18 studies, 11 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

Where their sites are

  • United States129 studies, 59 as a primary outcome
  • France44 studies, 12 as a primary outcome
  • Italy38 studies, 15 as a primary outcome
  • Belgium28 studies, 7 as a primary outcome
  • Canada28 studies, 8 as a primary outcome
  • Germany28 studies, 5 as a primary outcome
  • Spain25 studies, 9 as a primary outcome
  • United Kingdom24 studies, 3 as a primary outcome
  • Denmark22 studies, 6 as a primary outcome
  • Czechia19 studies, 5 as a primary outcome
  • Poland19 studies, 4 as a primary outcome
  • Türkiye19 studies, 6 as a primary outcome

62 countries in all. A study with sites in several counts in each; 18 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name the Paced Visual Serial Addition Test: 110 of 202, 54%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name the Paced Visual Serial Addition Test and every completed study, by how they reported results
ResultsCompleted studies that name the Paced Visual Serial Addition TestEvery completed study
Results on ClinicalTrials.gov and a paper26, 13%776, 10%
Results on ClinicalTrials.gov only29, 14%1,139, 14%
A results paper only55, 27%1,711, 22%
Neither92, 46%4,327, 54%

Tests named in the same studies

The library tests that studies naming the Paced Visual Serial Addition Test name most often beside it.
  1. 1

    Symbol Coding103 studies, 51 as a primary outcome

  2. 2

    Verbal Learning72 studies, 37 as a primary outcome

  3. 3

    Verbal Fluency72 studies, 29 as a primary outcome

  4. 4

    Trail Making Test54 studies, 26 as a primary outcome

  5. 5

    Stroop Color-Word Test51 studies, 24 as a primary outcome

  6. 6

    Digit Span Test41 studies, 22 as a primary outcome

  7. 7

    Selective Reminding Task21 studies, 10 as a primary outcome

  8. 8

    Continuous Performance Test18 studies, 8 as a primary outcome

  9. 9

    Card Sorting Test (Berg)16 studies, 13 as a primary outcome

  10. 10

    Category Fluency15 studies, 8 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for the Paced Visual Serial Addition Test and the tests named with it most. Add or remove tests to compare.
Paced Visual Serial Addition Test333 studies, 2000 to 2026
01002002000201020202026
Symbol Coding1,448 studies, 2000 to 2026
01002002000201020202026
Verbal Learning1,819 studies, 2000 to 2026
01002002000201020202026
Verbal Fluency1,737 studies, 2000 to 2026
01002002000201020202026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table
Registered studies per start year that name each test
Start yearPaced Visual Serial Addition TestSymbol CodingVerbal LearningVerbal Fluency
20000111
20011251
20025383
200333144
2004211149
2005071719
200648139
20074142222
20085142818
200912182829
20109284229
201112303336
201210274234
201316355358
201418478259
201518399179
201625729885
2017207110793
2018228392107
20192994122121
202013797690
202121116137131
202220107138123
202321140157147
202419134144130
20258134132167
202616131123133

Explore the 337 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.
TestThe Paced Visual Serial Addition Test

337 studies match. 140 name the Paced Visual Serial Addition Test in a primary outcome. Median size 61 participants. Median time to the primary outcome: 12 weeks.

Loading 337 studies; the filters turn on when they arrive.

By start year
01020302000: 0 studies, 0 naming the Paced Visual Serial Addition Test in a primary outcome20002001: 1 studies, 0 naming the Paced Visual Serial Addition Test in a primary outcome2002: 5 studies, 1 naming the Paced Visual Serial Addition Test in a primary outcome2003: 3 studies, 2 naming the Paced Visual Serial Addition Test in a primary outcome2004: 2 studies, 1 naming the Paced Visual Serial Addition Test in a primary outcome2005: 0 studies, 0 naming the Paced Visual Serial Addition Test in a primary outcome20052006: 4 studies, 0 naming the Paced Visual Serial Addition Test in a primary outcome2007: 4 studies, 0 naming the Paced Visual Serial Addition Test in a primary outcome2008: 5 studies, 1 naming the Paced Visual Serial Addition Test in a primary outcome2009: 12 studies, 6 naming the Paced Visual Serial Addition Test in a primary outcome2010: 9 studies, 5 naming the Paced Visual Serial Addition Test in a primary outcome20102011: 12 studies, 6 naming the Paced Visual Serial Addition Test in a primary outcome2012: 10 studies, 4 naming the Paced Visual Serial Addition Test in a primary outcome2013: 16 studies, 9 naming the Paced Visual Serial Addition Test in a primary outcome2014: 18 studies, 10 naming the Paced Visual Serial Addition Test in a primary outcome2015: 18 studies, 7 naming the Paced Visual Serial Addition Test in a primary outcome20152016: 25 studies, 9 naming the Paced Visual Serial Addition Test in a primary outcome2017: 20 studies, 7 naming the Paced Visual Serial Addition Test in a primary outcome2018: 22 studies, 9 naming the Paced Visual Serial Addition Test in a primary outcome2019: 29 studies, 11 naming the Paced Visual Serial Addition Test in a primary outcome2020: 13 studies, 6 naming the Paced Visual Serial Addition Test in a primary outcome20202021: 21 studies, 11 naming the Paced Visual Serial Addition Test in a primary outcome2022: 20 studies, 7 naming the Paced Visual Serial Addition Test in a primary outcome2023: 21 studies, 9 naming the Paced Visual Serial Addition Test in a primary outcome2024: 19 studies, 9 naming the Paced Visual Serial Addition Test in a primary outcome2025: 8 studies, 5 naming the Paced Visual Serial Addition Test in a primary outcome20252026: 16 studies, 4 naming the Paced Visual Serial Addition Test in a primary outcome

2026 is partly planned starts. Not shown: 1 that started before 2000 and 3 planned to start after 2026.

Show as a table
Matching studies by start year
Start yearStudiesAs a primary outcome
200000
200110
200251
200332
200421
200500
200640
200740
200851
2009126
201095
2011126
2012104
2013169
20141810
2015187
2016259
2017207
2018229
20192911
2020136
20212111
2022207
2023219
2024199
202585
2026164

Library tests named most

  • Paced Visual Serial Addition Test337 studies, 140 as a primary outcome
  • Symbol Coding103 studies, 51 as a primary outcome
  • Verbal Learning72 studies, 37 as a primary outcome
  • Verbal Fluency72 studies, 29 as a primary outcome
  • Trail Making Test54 studies, 26 as a primary outcome
  • Stroop Color-Word Test51 studies, 24 as a primary outcome
  • Digit Span Test41 studies, 22 as a primary outcome
  • Selective Reminding Task21 studies, 10 as a primary outcome
  • Continuous Performance Test18 studies, 8 as a primary outcome
  • Card Sorting Test (Berg)16 studies, 13 as a primary outcome

Largest condition groups

Phases

Participants

Lead sponsor: industry 50, NIH 2, other 285. Interventional 289, observational 48.

As a primary outcomeSecondary or other outcomeThe Paced Visual Serial Addition Test

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
StudyStartPhaseConditionsParticipantsLead sponsorStatusLibrary tests named, with the latest time point
NCT07882433Start2026PhaseNot applicableConditionsSleep and sleep disordersParticipants50Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Trail Making TestSecondary6 months
  • Stroop Color-Word TestSecondary6 months
  • Verbal FluencySecondary6 months
  • Digit Span TestSecondary6 months
  • Paced Visual Serial Addition TestSecondary6 months
NCT07870187Start2027PhasePhase 1ConditionsSubstance use and addictionParticipants70Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Symbol CodingPrimarysame day
  • Paced Visual Serial Addition TestPrimarysame day
NCT07854093Start2026PhaseObservationalConditionsEpilepsyParticipants40Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Paced Visual Serial Addition TestSecondarysame day
NCT07842302Start2026PhaseNot applicableConditionsMultiple sclerosis, Pain and fatigueParticipants80Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Trail Making TestSecondary6 months
  • Stroop Color-Word TestSecondary6 months
  • Verbal FluencySecondary6 months
  • Symbol CodingPrimary6 months
  • Paced Visual Serial Addition TestSecondary6 months
  • Selective Reminding TaskSecondary6 months
NCT07827716Start2026PhasePhase 2ConditionsMultiple sclerosisParticipants100Lead sponsorOtherStatusRecruitingLibrary tests named
  • Symbol CodingSecondary12 months
  • Paced Visual Serial Addition TestSecondary12 months
NCT07812935Start2025PhaseNot applicableConditionsCardiovascular diseaseParticipants33Lead sponsorOtherStatusCompletedLibrary tests named
  • Paced Visual Serial Addition TestPrimary4 weeks
NCT07806877Start2026PhaseNot applicableConditionsSchizophrenia and psychosisParticipants60Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Stroop Color-Word TestPrimary6 weeks
  • N-Back TaskSecondary6 weeks
  • Card Sorting Test (Berg)Primary6 weeks
  • Paced Visual Serial Addition TestPrimary6 weeks
  • Oddball Target DetectionSecondary6 weeks
NCT07734675Start2026PhaseNot applicableConditionsMultiple sclerosisParticipants130Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Stroop Color-Word TestPrimary2 years
  • Verbal LearningPrimary2 years
  • Symbol CodingPrimary2 years
  • Picture Naming TestPrimary2 years
  • Paced Visual Serial Addition TestPrimary2 years
  • Cancellation TestPrimary2 years
  • Selective Reminding TaskPrimary2 years
NCT07640100Start2026PhaseNot applicableConditionsMultiple sclerosisParticipants45Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Paced Visual Serial Addition TestSecondary8 weeks
NCT07576413Start2018PhaseNot applicableConditionsOther conditionsParticipants31Lead sponsorOtherStatusCompletedLibrary tests named
  • Continuous Performance TestSecondarysame day
  • Paced Visual Serial Addition TestSecondarysame day
  • Eriksen Flanker TaskSecondarysame day
  • AX Continuous Performance TestWording unclear
  • Arithmetic Fluency TaskSecondarysame day
NCT07571304Start2026PhaseNot applicableConditionsMultiple sclerosisParticipants22Lead sponsorOtherStatusRecruitingLibrary tests named
  • Verbal LearningPrimary8 weeks
  • Symbol CodingPrimary8 weeks
  • Paced Visual Serial Addition TestSecondary8 weeks
NCT07546721Start2026PhaseNot applicableConditionsMultiple sclerosisParticipants12Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Stroop Color-Word TestSecondary6 months
  • Symbol CodingSecondary12 weeks
  • Paced Visual Serial Addition TestSecondary12 weeks
NCT07429526Start2013PhaseNot applicableConditionsStroke, Brain injury and concussion, Pain and fatigueParticipants12Lead sponsorOtherStatusCompleted

Paper

Library tests named
  • Verbal LearningPrimary13 weeks
  • Digit Span TestPrimary13 weeks
  • Paced Visual Serial Addition TestPrimary13 weeks
NCT07427329Start2025PhaseNot applicableConditionsAging, frailty and exercise, Pain and fatigueParticipants434Lead sponsorOtherStatusActive, not recruitingLibrary tests named
  • Stroop Color-Word TestSecondary9 months
  • Psychomotor Vigilance TaskSecondary9 months
  • Paced Visual Serial Addition TestPrimary9 months
NCT07374237Start2025PhaseObservationalConditionsMultiple sclerosis, Sleep and sleep disorders, Pain and fatigueParticipants102Lead sponsorOtherStatusCompletedLibrary tests named
  • Paced Visual Serial Addition TestPrimary
NCT07273604Start2015PhaseNot applicableConditionsMultiple sclerosis, Depression and bipolar disorder, Anxiety, PTSD and OCD, Pain and fatigueParticipants148Lead sponsorOtherStatusCompletedLibrary tests named
  • Verbal FluencyPrimary12 weeks
  • Symbol CodingPrimary12 weeks
  • Category FluencyPrimary12 weeks
  • Paced Visual Serial Addition TestPrimary12 weeks
  • Selective Reminding TaskPrimary12 weeks
NCT07262658Start2022PhaseObservationalConditionsParkinson's diseaseParticipants40Lead sponsorOtherStatusCompletedLibrary tests named
  • Trail Making TestPrimarysame day
  • Verbal LearningPrimarysame day
  • Verbal FluencyPrimarysame day
  • Category FluencyPrimarysame day
  • Card Sorting Test (Berg)Primarysame day
  • Paced Visual Serial Addition TestPrimarysame day
  • Symbol Scan TaskPrimarysame day
NCT07257900Start2025PhaseNot applicableConditionsMultiple sclerosis, Aging, frailty and exerciseParticipants30Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Paced Visual Serial Addition TestSecondary8 weeks
NCT07216690Start2026PhasePhase 2ConditionsSubstance use and addictionParticipants20Lead sponsorOtherStatusRecruitingLibrary tests named
  • Symbol CodingPrimarysame day
  • Paced Visual Serial Addition TestPrimarysame day
NCT07214155Start2026PhasePhase 1ConditionsSubstance use and addictionParticipants70Lead sponsorOtherStatusRecruitingLibrary tests named
  • Symbol CodingPrimarysame day
  • Paced Visual Serial Addition TestPrimarysame day
NCT07189325Start2026PhasePhase 3ConditionsMultiple sclerosisParticipants250Lead sponsorOtherStatusRecruitingLibrary tests named
  • Paced Visual Serial Addition TestOther outcome3 years
NCT07114809Start2024PhaseNot applicableConditionsMultiple sclerosisParticipants80Lead sponsorOtherStatusRecruitingLibrary tests named
  • Verbal LearningPrimary6 months
  • Symbol CodingPrimary6 months
  • Paced Visual Serial Addition TestPrimary6 months
NCT07058896Start2024PhaseNot applicableConditionsMultiple sclerosisParticipants18Lead sponsorOtherStatusRecruitingLibrary tests named
  • Paced Visual Serial Addition TestSecondary13 weeks
NCT07058870Start2024PhaseNot applicableConditionsMultiple sclerosisParticipants18Lead sponsorOtherStatusRecruitingLibrary tests named
  • Paced Visual Serial Addition TestSecondary13 weeks
NCT06964581Start2023PhaseNot applicableConditionsMultiple sclerosisParticipants60Lead sponsorOtherStatusRecruitingLibrary tests named
  • Trail Making TestSecondary9 weeks
  • Verbal FluencySecondary9 weeks
  • Symbol CodingSecondary9 weeks
  • Go/No-Go TaskSecondary9 weeks
  • Paced Visual Serial Addition TestPrimary9 weeks
  • Design Fluency TestSecondary9 weeks

Page 1 of 14

Questions, answered from the data

How many clinical trials use the Paced Visual Serial Addition Test?

337 registered studies on ClinicalTrials.gov name it in an outcome measure, 140 of them in a primary outcome.

In which conditions do trials use the Paced Visual Serial Addition Test?

Most often in multiple sclerosis (169), substance use and addiction (30) and pain and fatigue (28).

Do new trials use the Paced Visual Serial Addition Test more or less?

1.3% of the studies that started in 2021 to 2025 name it, against 2.4% of those that started in 2016 to 2020: a share 48% smaller.

Which tests do trials use with the Paced Visual Serial Addition Test?

Symbol Coding (103 studies), Verbal Learning (72 studies) and Verbal Fluency (72 studies).

How many participants do phase 2 trials that use the Paced Visual Serial Addition Test enroll?

Half of the phase 2 studies that name it enroll 64 participants or fewer, and the middle half enroll 37 to 115. 30 of them give a size.

When do trials measure the Paced Visual Serial Addition Test?

Half of the primary outcomes that name the Paced Visual Serial Addition Test are measured within 12 weeks of the start, and the middle half from 1 week to 8 months. 126 primary outcomes give a duration.

How many completed trials that use the Paced Visual Serial Addition Test have reported results?

110 of the 202 completed studies that name it, 54%, have reported results: 55 posted them on ClinicalTrials.gov, 81 have a results paper linked to the registry record, and 26 did both. The other 92 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.

More on tests in clinical trials

  • Paced Visual Serial Addition Test: what it measures, its scores, and a version to try
  • All 101 tests in clinical trials
  • Cognitive tests by condition
  • Every registered study, by test, condition, phase and year

How the studies are counted

For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.

The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.

A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.

A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.

Run the Paced Visual Serial Addition Test in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free
ConductCognition

Hosted browser-native cognitive testing for academic and commercial research workflows.

A product of ConductScience, Inc.

New tests and features, about once a month. Unsubscribe at any time.

Tests

  • All cognitive tests
  • Test batteries
  • Use and evidence
  • Test norms
  • Trail Making Test
  • N-Back Task
  • Automated scoring
  • Study design
  • New tests by email

Guides

  • Methods and questions
  • Blog
  • Recruitment setup
  • Participant devices
  • Prolific
  • Sona Systems
  • CloudResearch Connect
  • Qualtrics

Use cases

  • Student participant pools
  • Aging and dementia research
  • Clinical trials
  • US clinical research
  • Remote testing

Compare and buy

  • Pricing
  • Compare platforms
  • Offline edition
  • FAQ

Trust

  • Study Quality Monitor
  • HIPAA-ready testing
  • Data export
  • Privacy Policy
  • Terms of Use
  • Data Policy

Company

  • ConductScience
  • Affiliate Program
© 2026 ConductScience, Inc. Research use only.